Nektar Therapeutics Financing Cash Flow
Nektar Therapeutics (NKTR) reported Financing Cash Flow of $894.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- Nektar Therapeutics net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $364.57M, a 172681.52% increase year-over-year.
- Nektar Therapeutics net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $529.55M, a 7564885.71% increase year-over-year.
- Nektar Therapeutics net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $38.67M, a 46491.57% increase year-over-year.
- Nektar Therapeutics net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $141.68M, a 1089723.08% increase year-over-year.
- Nektar Therapeutics net cash provided by (used in) financing activities for fiscal 2025 was $180.57M, a 328.71% increase from fiscal 2024.
- Nektar Therapeutics net cash provided by (used in) financing activities for fiscal 2024 was $42.12M, a 140293.33% increase from fiscal 2023.
- Nektar Therapeutics net cash provided by (used in) financing activities for fiscal 2023 was $30.00K, a 98.01% decline from fiscal 2022.
- Nektar Therapeutics net cash provided by (used in) financing activities for fiscal 2022 was $1.51M, a 95.84% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $364.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $894.12M 10-Q · filed 2026-08-14 | $932.79M derived: sum of 3 quarters · filed 2026-08-14 | $1.07B derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $529.55M 10-Q · filed 2026-05-08 | $568.22M derived: sum of 2 quarters · filed 2026-05-08 | $709.90M derived: sum of 3 quarters · filed 2026-05-08 | $710.11M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $38.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $180.35M derived: sum of 2 quarters · filed 2026-03-13 | $180.56M derived: sum of 3 quarters · filed 2026-08-14 | $180.57M 10-K · filed 2026-03-13 |
| 2025-09-30 | $141.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $141.89M derived: sum of 2 quarters · filed 2026-08-14 | $141.90M 10-Q · filed 2025-11-07 | $141.98M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $218.00K 10-Q · filed 2026-08-14 | $301.00K derived: sum of 3 quarters · filed 2026-08-14 | $314.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-08 | $90.00K derived: sum of 2 quarters · filed 2026-05-08 | $103.00K derived: sum of 3 quarters · filed 2026-05-08 | $122.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $96.00K derived: sum of 2 quarters · filed 2026-03-13 | $115.00K derived: sum of 3 quarters · filed 2026-03-13 | $42.12M 10-K · filed 2026-03-13 |
| 2024-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $32.00K derived: sum of 2 quarters · filed 2025-11-07 | $42.03M 10-Q · filed 2025-11-07 | $42.05M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $42.02M 10-Q · filed 2025-08-08 | $42.03M derived: sum of 3 quarters · filed 2025-08-08 | $42.03M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $42.00M 10-Q · filed 2025-05-09 | $42.02M derived: sum of 2 quarters · filed 2025-05-09 | $42.02M derived: sum of 3 quarters · filed 2025-05-09 | $42.03M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $12.00K derived: sum of 2 quarters · filed 2025-03-14 | $30.00K derived: sum of 3 quarters · filed 2025-03-14 | $30.00K 10-K · filed 2025-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $18.00K derived: sum of 2 quarters · filed 2024-11-08 | $18.00K 10-Q · filed 2024-11-08 | $121.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $18.00K 10-Q · filed 2024-08-09 | $121.00K derived: sum of 3 quarters · filed 2024-08-09 | $121.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $103.00K derived: sum of 2 quarters · filed 2024-05-10 | $103.00K derived: sum of 3 quarters · filed 2024-05-10 | $570.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $103.00K derived: sum of 2 quarters · filed 2024-03-05 | $570.00K derived: sum of 3 quarters · filed 2024-03-05 | $1.51M 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $467.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.41M 10-Q · filed 2023-11-08 | $3.96M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.41M 10-Q · filed 2023-08-09 | $3.96M derived: sum of 3 quarters · filed 2024-03-05 | $7.62M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $938.00K 10-Q · filed 2023-05-10 | $3.49M derived: sum of 2 quarters · filed 2024-03-05 | $7.15M derived: sum of 3 quarters · filed 2024-03-05 | $19.32M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $6.21M derived: sum of 2 quarters · filed 2024-03-05 | $18.38M derived: sum of 3 quarters · filed 2024-03-05 | $36.24M 10-K · filed 2024-03-05 |
| 2021-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $15.83M derived: sum of 2 quarters · filed 2022-11-04 | $33.69M 10-Q · filed 2022-11-04 | $182.68M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $12.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $30.02M 10-Q · filed 2022-08-05 | $179.02M derived: sum of 3 quarters · filed 2023-02-28 | $180.55M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $17.86M 10-Q · filed 2022-05-06 | $166.85M derived: sum of 2 quarters · filed 2023-02-28 | $168.38M derived: sum of 3 quarters · filed 2023-02-28 | -$73.58M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $149.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $150.53M derived: sum of 2 quarters · filed 2023-02-28 | -$91.43M derived: sum of 3 quarters · filed 2023-02-28 | -$80.35M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$240.43M derived: sum of 2 quarters · filed 2021-11-05 | -$229.35M 10-Q · filed 2021-11-05 | -$224.44M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$241.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$230.88M 10-Q · filed 2021-08-06 | -$225.97M derived: sum of 3 quarters · filed 2022-03-01 | -$219.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $11.08M 10-Q · filed 2021-05-07 | $15.98M derived: sum of 2 quarters · filed 2022-03-01 | $22.23M derived: sum of 3 quarters · filed 2022-03-01 | $29.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $11.15M derived: sum of 2 quarters · filed 2022-03-01 | $18.46M derived: sum of 3 quarters · filed 2022-03-01 | $23.36M 10-K · filed 2022-03-01 |
| 2019-09-30 | $6.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $13.55M derived: sum of 2 quarters · filed 2020-11-06 | $18.45M 10-Q · filed 2020-11-06 | $21.12M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $7.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $12.20M 10-Q · filed 2020-08-07 | $14.87M derived: sum of 3 quarters · filed 2021-02-26 | $18.73M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $4.89M 10-Q · filed 2020-05-08 | $7.56M derived: sum of 2 quarters · filed 2021-02-26 | $11.42M derived: sum of 3 quarters · filed 2021-02-26 | $822.51M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $6.53M derived: sum of 2 quarters · filed 2021-02-26 | $817.61M derived: sum of 3 quarters · filed 2021-02-26 | $851.97M 10-K · filed 2021-02-26 |
| 2018-09-30 | $3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $814.95M derived: sum of 2 quarters · filed 2019-11-07 | $849.30M 10-Q · filed 2019-11-07 | $873.57M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $811.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $845.44M 10-Q · filed 2019-08-09 | $869.71M derived: sum of 3 quarters · filed 2020-02-28 | $879.18M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $34.35M 10-Q · filed 2019-05-09 | $58.63M derived: sum of 2 quarters · filed 2020-02-28 | $68.10M derived: sum of 3 quarters · filed 2020-02-28 | |
| 2017-12-31 | $24.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $33.74M derived: sum of 2 quarters · filed 2020-02-28 | $54.39M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $9.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $30.12M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $20.65M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $203.62M 10-K · filed 2019-03-01 | |||
| 2013-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $4.06M derived: sum of 2 quarters · filed 2014-02-27 | $4.69M derived: sum of 3 quarters · filed 2014-02-27 | $2.22M 10-K · filed 2014-02-27 |
| 2013-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.53M derived: sum of 2 quarters · filed 2013-11-07 | $52.00K 10-Q · filed 2013-11-07 | $262.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-06-30 | $629.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$1.84M 10-Q · filed 2013-08-09 | -$1.64M derived: sum of 3 quarters · filed 2014-02-27 | -$94.82M derived: sum of 4 quarters · filed 2014-02-27 |
| 2013-03-31 | -$2.47M 10-Q · filed 2013-05-09 | -$2.26M derived: sum of 2 quarters · filed 2014-02-27 | -$95.45M derived: sum of 3 quarters · filed 2014-02-27 | -$95.17M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$92.97M derived: sum of 2 quarters · filed 2014-02-27 | -$92.70M derived: sum of 3 quarters · filed 2014-02-27 | $26.80M 10-K · filed 2014-02-27 |
| 2012-09-30 | -$93.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$92.91M derived: sum of 2 quarters · filed 2013-11-07 | $26.59M 10-Q · filed 2013-11-07 | $26.29M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $119.78M 10-Q · filed 2013-08-09 | $119.47M derived: sum of 3 quarters · filed 2014-02-27 | $119.50M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $119.50M 10-Q · filed 2013-05-09 | $119.20M derived: sum of 2 quarters · filed 2014-02-27 | $119.22M derived: sum of 3 quarters · filed 2014-02-27 | $120.34M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$280.00K derived: sum of 2 quarters · filed 2014-02-27 | $836.00K derived: sum of 3 quarters · filed 2014-02-27 | $222.34M 10-K · filed 2014-02-27 |
| 2011-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.14M derived: sum of 2 quarters · filed 2012-11-09 | $222.64M 10-Q · filed 2012-11-09 | $224.15M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $222.62M 10-Q · filed 2012-08-09 | $224.13M derived: sum of 3 quarters · filed 2013-03-01 | $224.73M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $221.50M 10-Q · filed 2012-05-04 | $223.01M derived: sum of 2 quarters · filed 2013-03-01 | $223.62M derived: sum of 3 quarters · filed 2013-03-01 | $224.62M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $2.12M derived: sum of 2 quarters · filed 2013-03-01 | $3.12M derived: sum of 3 quarters · filed 2013-03-01 | $7.54M 10-K · filed 2013-03-01 |
| 2010-09-30 | $606.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $1.61M derived: sum of 2 quarters · filed 2011-11-04 | $6.02M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $5.42M 10-Q · filed 2011-08-05 | ||
| 2010-03-31 | $4.42M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $3.54M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |